| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 143.41B | 137.68B | 127.98B | 112.23B | 106.72B | 107.25B |
| Gross Profit | 23.58B | 21.49B | 18.33B | 15.37B | 14.20B | 13.57B |
| EBITDA | 13.28B | 12.01B | 9.74B | 7.54B | 7.36B | 6.86B |
| Net Income | 10.54B | 9.66B | 7.17B | 5.60B | 5.40B | 4.64B |
Balance Sheet | ||||||
| Total Assets | 100.22B | 118.17B | 117.35B | 109.15B | 99.97B | 98.63B |
| Cash, Cash Equivalents and Short-Term Investments | 18.18B | 20.57B | 13.63B | 25.00B | 15.57B | 12.17B |
| Total Debt | 329.00M | 3.86B | 9.96B | 3.73B | 4.21B | 6.94B |
| Total Liabilities | 31.25B | 48.87B | 51.75B | 50.93B | 46.15B | 47.93B |
| Stockholders Equity | 68.97B | 69.29B | 65.59B | 58.21B | 53.81B | 50.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.03B | -13.74B | 12.60B | 6.81B | 1.83B |
| Operating Cash Flow | 0.00 | 14.24B | -13.56B | 12.82B | 7.00B | 1.92B |
| Investing Cash Flow | 0.00 | 2.05B | -783.00M | -1.17B | 414.00M | 309.00M |
| Financing Cash Flow | 0.00 | -10.18B | 2.52B | -2.27B | -4.41B | -2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥170.64B | 11.69 | ― | 2.81% | 17.47% | 85.08% | |
78 Outperform | ¥259.59B | 9.89 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥653.91B | 11.33 | ― | 2.15% | 0.46% | 38.67% | |
77 Outperform | ¥97.43B | 6.30 | ― | 4.38% | -6.07% | 44.83% | |
64 Neutral | ¥167.57B | 18.57 | ― | 2.87% | -1.92% | -12.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥57.83B | 11.64 | ― | 2.95% | 8.72% | 139.76% |